Literature DB >> 19278438

Ehlers-Danlos syndrome--vascular type (ecchymotic variant): cutaneous and dermatopathologic features.

Nand L Sharma1, Vikram K Mahajan, Neelam Gupta, Nitin Ranjan, Anju Lath.   

Abstract

Ehlers-Danlos syndrome - vascular type, the only lethal form, is rarely reported in dermatology literature. It is characterized by translucent, atrophic skin, easy bruising, arterial, intestinal and/or uterine fragility manifesting as varicose veins, aneurysms and vascular/visceral/uterine rupture. As its dermatopathologic features are not well elucidated, diagnosis is often made after a catastrophic complication or at autopsy. This 36 year-old non-consanguineous male had brown-black plaques with atrophy and frequent ulceration over legs and dorsal feet and tortuous varicose veins around ankles for the past 15 years. Perivenous skin was translucent and hypopigmented. He had multiple and ecchymotic keloids and small atrophic, pityriasis versicolor-like lesions over trunk. He did not have hypermobile/hyperextensible skin and joints and showed no systemic or investigative abnormality. Histopathologic features of atrophic lesion included blood extravasation in atrophic epidermis/dermis, focal clustering and dilatation of blood vessels, malformed vessel walls, abundant hemosiderin in the dermis and homogenously stained/whorled patterned collagen especially around blood vessels. Pathology of keloidal lesion showed new collagen and vascular fragility. These histopathologic features appear of diagnostic value especially in patients who have compatible clinical findings but cannot afford confirmation by biochemical testing for abnormal synthesis of type III procollagen or identification of mutations in the COL3A1 gene.

Entities:  

Mesh:

Year:  2009        PMID: 19278438     DOI: 10.1111/j.1600-0560.2008.01065.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  4 in total

1.  Diminished type III collagen promotes myofibroblast differentiation and increases scar deposition in cutaneous wound healing.

Authors:  Susan W Volk; Yanjian Wang; Elizabeth A Mauldin; Kenneth W Liechty; Sherrill L Adams
Journal:  Cells Tissues Organs       Date:  2011-01-19       Impact factor: 2.481

2.  Myofibroblast expression in skin wounds is enhanced by collagen III suppression.

Authors:  Mohammed M Al-Qattan; Mervat M Abd-Elwahed; Khalid Hawary; Maha M Arafah; Medhat K Shier
Journal:  Biomed Res Int       Date:  2015-02-19       Impact factor: 3.411

3.  In vitro fibrillogenesis of tropocollagen type III in collagen type I affects its relative fibrillar topology and mechanics.

Authors:  Meisam Asgari; Neda Latifi; Hossein K Heris; Hojatollah Vali; Luc Mongeau
Journal:  Sci Rep       Date:  2017-05-03       Impact factor: 4.379

4.  A tissue-mimetic nano-fibrillar hybrid injectable hydrogel for potential soft tissue engineering applications.

Authors:  Neda Latifi; Meisam Asgari; Hojatollah Vali; Luc Mongeau
Journal:  Sci Rep       Date:  2018-01-18       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.